By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: BOSS Zhipin Surpasses RMB540 Million in Share Repurchases in 2026
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > BOSS Zhipin Surpasses RMB540 Million in Share Repurchases in 2026
BOSS Zhipin Surpasses RMB540 Million in Share Repurchases in 2026
Technology

BOSS Zhipin Surpasses RMB540 Million in Share Repurchases in 2026

GlobeNews Wire
Last updated: 30/03/2026 3:37 PM
GlobeNews Wire
Published: 30/03/2026
Share
SHARE

BEIJING, March 30, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB34.5 million to repurchase 759,056 ordinary shares on March 27. Year-to-date in 2026, the Company has deployed over RMB540 million toward share repurchases. This move underscores the Company’s ongoing commitment to shareholder returns.



Medical AI Named First-Ever Recipient of ACC Global Digital Health Award at American College of Cardiology Annual Scientific Session
Adyen Expands In Person Payments Offering With Launch of Two New Terminals
Golden Suisse and Professor Joseph Stiglitz Convene Global UHNWI Summit
Sustainability Report 2024: ENNOVI Earns EcoVadis Platinum, CDP Recognition and Gold Asia Sustainability Award
Crescent Biopharma Announces Grants of Inducement Awards
TAGGED:2026bossHKSE:2076KYG5224V1032millionNasdaq:BZnewsrepurchasesrmb540sharesurpassesUS48553T1060zhipin
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Health

Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences

GlobeNews Wire
GlobeNews Wire
01/09/2025
Pictor and Disease Research Limited Formalise Collaboration to Advance Johne’s Disease Monitoring Across New Zealand
Ultima Markets Celebrates 10th Anniversary
Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”
Rakuten Symphony and Tejas Networks announce partnership to drive Global Expansion through Interoperable 5G Solutions
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?